Drum Hill Capital’s AbbVie ABBV Stock Holding History

Drum Hill Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$271K	Sell	1,077 -50	-4%	-$10.8K	0.28%	42
2026 Q1	$245K	Hold	1,127	–	–	0.23%	39
2025 Q4	$258K	Hold	1,127	–	–	0.27%	40
2025 Q3	$261K	Hold	1,127	–	–	0.28%	41
2025 Q2	$209K	Hold	1,127	–	–	0.23%	46
2025 Q1	$236K	Buy	+1,127	New	+$219K	0.27%	41

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Drum Hill Capital's ABBV Position: Q2 2026 in Review

Drum Hill Capital reduced its AbbVie (ABBV) stake by 4.4% in Q2 2026, selling an estimated $10.8K and leaving 1,077 shares worth $271K. The position accounts for 0.28% of the portfolio, ranked #42.

Drum Hill Capital first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Drum Hill Capital held 1,077 shares of AbbVie worth $271K as of Q2 2026.
Drum Hill Capital sold 50 AbbVie shares in Q2 2026, an estimated $10.8K.
AbbVie made up 0.28% of Drum Hill Capital's portfolio in Q2 2026, its #42 holding.
Drum Hill Capital first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Drum Hill Capital's 13F filing for Q2 2026, filed 31 Jul 2026.